The present invention relates to drugs consisting of unsaturated fatty amino-acid derivatives of the general formula (I), and to their pharmaceutically acceptable acid addition salts, in which: X is oxygen or NH, Rn are independently hydrogen or a (C
1
-C
6
)alkyl optionally substituted by halogen; R
1
is hydrogen, fluorine, chlorine or bromine, or a CF
3
or CHF
2
or a (C
1
-C
6
)alkyl, (C
1
-C
6
)alkenyl or (C
1
-C
6
)alkynyl, optionally substituted by one or more halogen atoms; R is hydrogen or a (C
1
-C
6
)alkyl or (C
3
-C
6
)cycloalkyl optionally substituted by one or more halogen atoms; Ra and Rb are independently hydrogen (C
1
-C
6
)alkyl or (C
1
-C
6
)acyl, and Ra and Rb a hydrocarbonated cycle containing 4 to 6 carbon atoms; and n is an integer between 2 and 14.
本发明涉及一种由通式(I)的不饱和
脂肪氨基酸衍
生物组成的药物,以及它们的药用可接受的酸盐,其中:X为
氧或NH,Rn独立地为
氢或经卤素取代的(C1-C6)烷基;R1为
氢、
氟、
氯或
溴,或者为
CF3或
CHF2或(C1-C6)烷基、(C1-C6)
烯基或(C1-C6)炔基,可以经过一个或多个卤素原子的取代;R为
氢或者经过一个或多个卤素原子取代的(C1-C6)烷基或(C3-C6)
环烷基;Ra和Rb独立地为
氢、(C1-C6)烷基或(C1-C6)酰基,而Ra和Rb为含有4到6个
碳原子的
碳氢化合物环;n为介于2和14之间的整数。